ZKN013
Familial Adenomatous Polyposis (APC mutation)
PreclinicalActive
Key Facts
Indication
Familial Adenomatous Polyposis (APC mutation)
Phase
Preclinical
Status
Active
About Eloxx Pharmaceuticals
Ribosome‑targeted small‑molecule platform for rare genetic diseases and cancer.
View full company profileAbout Eloxx Pharmaceuticals
Ribosome‑targeted small‑molecule platform for rare genetic diseases and cancer.
View full company profile